Prof. Dr. Edit Búzás
Prof. Dr. Edit Buzás is a distinguished physician-scientist and a globally recognized leader in immunology and extracellular vesicle research. As Professor of Immunology and Chair at Semmelweis University, she has played a pivotal role in advancing the understanding of extracellular vesicles and their functions in immune regulation, inflammation, and disease.
Her work has significantly shaped the scientific and translational landscape of extracellular vesicle biology, contributing to both fundamental discoveries and clinical applications. She is widely regarded as one of the pioneers of the field, with a strong international impact on research standards and innovation.
Beyond her academic contributions, she has held key leadership roles, including serving as Past President of the International Society for Extracellular Vesicles (ISEV), and is a member of several prestigious scientific academies. With her deep expertise and global influence, she continues to drive advancements at the intersection of immunology, cell biology, and biomedical innovation.
Batu DurgundeÄŸil
Batu DurgundeÄŸil is a Turkish businessman with over 15 years of experience in international trade, import, and business development. Throughout his career, he has focused on building strong relationships with manufacturers and suppliers across different markets, with a particular interest in creating stable and scalable business partnerships.
His experience includes identifying market opportunities, establishing reliable supply channels, and developing competitive business models in sectors where trust, consistency, and effective execution are essential. He is known for his practical and results-oriented approach to business.
Over the years, Batu DurgundeÄŸil has been involved in cross-border trade, supplier development, strategic sourcing, and market expansion projects. With an entrepreneurial mindset, he continues to explore new business and investment opportunities in both Turkey and international markets. He has also been honored with several awards by the Izmir Chamber of Commerce for his contributions and achievements in business.
Prof. Dr. Ender Berat Ellidokuz
Prof. Dr. Ender Berat Ellidokuz, MD, is a distinguished physician and academic with over 30 years of experience in Internal Medicine and Gastroenterology. After receiving his Medical Degree from Hacettepe University , he completed his specialty and fellowship training at Dokuz Eylül University, where he has since built a career at the intersection of clinical excellence and cutting-edge technology.
Throughout his career, Prof. Dr. Ellidokuz has expanded his focus beyond traditional clinical practice to include Bioinformatics, Health Technology, and Artificial Intelligence. His research is notably forward-thinking, exploring AI-driven diagnostics in colorectal cancer, gene overexpressions in gastric cancer, and the development of novel biomarkers through in silico identification.
He has served as a lead coordinator and researcher for numerous high-impact projects sponsored by TÜBÄ°TAK and TÜSEB, including the Turkish Genome Project and research into personalized organoid models for cancer treatment. With an entrepreneurial and results-oriented mindset, Prof. Dr. Ellidokuz continues to lead innovative studies in personalized medicine, bridging the gap between basic medical sciences and advanced engineering to improve patient outcomes.
Prof. Dr. Gökhan Karakülah
Prof. Dr. Gökhan Karakülah is a professor and researcher specializing in bioinformatics, computational biology, and genomics. With over a decade of experience in academia, he has focused on developing data-driven approaches to understand complex biological systems, particularly in cancer biology, transcriptomics, and systems biology.
Throughout his career, he has led and contributed to numerous national and international research projects, integrating multi-omics data, bioinformatics tool development, and translational research. His work emphasizes bridging computational methods with clinical applications, aiming to improve disease understanding, diagnosis, and treatment strategies.
He has supervised multiple graduate and doctoral students and played key roles in academic leadership and interdisciplinary collaborations. Known for his analytical thinking and innovation-driven mindset, he continues to advance research at the intersection of genomics, bioinformatics, and personalized medicine.
DoÄŸan TaÅŸkent
DoÄŸan TaÅŸkent is a seasoned technology and business leader with extensive experience spanning telecommunications, innovation management, and corporate strategy. With an academic background in electrical engineering from ETH Zürich and advanced studies at MIT and New York University, he has built a career at the intersection of technology, business, and entrepreneurship.
Throughout his career, he has held key leadership roles, including R&D positions at Lucent Technologies Bell Laboratories and CTO of Lucent Technologies Istanbul. He has also played a significant role in shaping the Turkish startup and technology transfer ecosystem through his work in corporate finance and innovation consultancy.
Currently serving as an executive board member responsible for R&D and innovation at Atabay Pharmaceuticals, he continues to drive strategic initiatives in technology and life sciences. Alongside his industry roles, he contributes to academia as a lecturer in technology and innovation management.
With a strong commitment to ecosystem building, DoÄŸan TaÅŸkent has been actively involved in numerous national and international organizations, holding leadership and advisory positions that support entrepreneurship, industry collaboration, and global partnerships.